logo
Jio BlackRock Mutual Fund launches investment management platform 'Aladdin'

Jio BlackRock Mutual Fund launches investment management platform 'Aladdin'

Jio BlackRock Mutual Fund, which last month got asset management licence from market regulator Sebi, on Monday introduced Aladdin, BlackRock's unique investment analytics and risk management platform.
Jio BlackRock Asset Management Pvt Ltd is a 50:50 joint venture between Jio Financial Services Ltd (JFSL) and US-based BlackRock.
"Investing should be simple. And it should work for you. That's the belief that brought Jio Financial Services and BlackRock together. We've blended Jio's digital first approach with BlackRock's global investment expertise? to build solutions around what Indian investors truly need," the mutual fund company said in a post on X.
And for the first time ever Aladdin, BlackRock's unique investment analytics and risk management platform, is now available in India, it said.
"This is just the beginning. We are here to redefine investing by making it accessible and affordable for you. We are Jio BlackRock Mutual Fund," it said.
The Securities and Exchange Board of India (Sebi), vide letter dated May 26, 2025, granted the certificate of registration to 'Jio BlackRock Mutual Fund' and approval to Jio BlackRock Asset Management Private Ltd to act as the asset management company for Jio BlackRock Mutual Fund.
The company, on October 29, 2024, announced incorporation of two firms -- Jio BlackRock Asset Management Private Limited and Jio BlackRock Trustee Private Limited - to carry on the primary business of mutual fund, subject to regulatory approvals.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘A homecoming for me': Aberdeen Vice Principal Siladitya Bhattacharya on India plans and academic vision
‘A homecoming for me': Aberdeen Vice Principal Siladitya Bhattacharya on India plans and academic vision

Hindustan Times

time30 minutes ago

  • Hindustan Times

‘A homecoming for me': Aberdeen Vice Principal Siladitya Bhattacharya on India plans and academic vision

The University Grants Commission (UGC) on Saturday formally granted the University of Aberdeen a Letter of Intent (LoI), allowing it to move forward with its proposal to establish a branch campus in Mumbai. Targeted for launch in September 2026, the campus marks a historic milestone, becoming the first Scottish university to be granted such permission in India. The LoI was awarded during a special ceremony in Mumbai hosted by the Government of India on 14 June, symbolising growing educational cooperation between the two nations. The initiative builds on Aberdeen's long-standing ties with India, forged through collaborations with over 200 institutions, including IITs, AIIMS, ICAR, Manipal Academy, and Delhi University. The proposed Mumbai campus is expected to launch with programmes in Computing and Data Science, Business Management, Economics, Artificial Intelligence, and an MBA. Future offerings may include Public Health, Mathematics, Psychology, Film Studies, and International Business—areas of mutual strategic interest. On this significant occasion, Professor Siladitya Bhattacharya, Vice-Principal for Global Engagement at the University of Aberdeen, spoke exclusively to Hindustan Times Digital about the university's India ambitions, academic vision, and what Indian students can expect. It's great to know that the University of Aberdeen is coming to India. What's exciting about this move, especially the decision to set up campus in Maharashtra? Thank you. Today is an important milestone for us. We've received a Letter of Intent from the University Grants Commission, granting us provisional approval to move ahead with our proposal to establish a campus in Mumbai. This signals our serious intent and marks the beginning of a significant journey. Our vision is to bring the quality, heritage, and ambition of a 500-year-old institution into a dynamic new setting. We want to learn from our students around the world while embracing the current globally connected knowledge ecosystem. We plan to begin with key programs in business and computing. Over time, we hope to expand into areas like public health, psychology, and even Film Studies—particularly fitting for Mumbai. A large share of our students at the Aberdeen campus come from around the world. Many want an Aberdeen degree, but not all can afford to travel to Northern Scotland. Thanks to support from both the central and Maharashtra governments, we now have the opportunity to bring our programs closer to students here. To understand that, we need to look back. We're a 500-year-old university with a global outlook. That ethos of openness remains central to our identity. Our current strategy, Aberdeen 2040, prioritises international, inclusive, sustainable, and interdisciplinary education. Our core purpose is to be open to all. With India's youthful demographic, this move aligns perfectly with our mission—to take our academic model to where the students are. Our programs reflect our values: inclusivity, internationalism, sustainability—both environmental and financial—and interdisciplinarity. Today's students don't just want pure specialisations. Business intersects with AI, entrepreneurship, and finance. Public health connects with management, global health, and even sports and exercise science. AI cuts across disciplines from hard sciences to the humanities. We also offer flexibility. At our home campus, students have the freedom to explore subjects before choosing their specialisation, thanks to Scotland's four-year undergraduate model. Students specialise in 3rd and 4th year. Our structure allows for flexibility through a combination of broad-based courses and specialised modules. We introduce research methods early, so students are prepared not just for jobs that exist today but also for careers that may not even exist yet. Sure. In medicine, for instance, we encourage students to explore humanities subjects like literature or art history. This creates well-rounded professionals who don't just extend life but understand its deeper value. That's the kind of education we believe in. That's where education needs to evolve. In a world where facts are instantly accessible, what truly matters is critical thinking—the ability to make informed, value-based decisions. Our teaching and assessments focus on analytical skills and real-world application, rather than rote memorisation. Medical programs in Scotland run for five years plus clinical training. In India, we plan to welcome our first batch in September 2026, starting with business and computing programs. Initially, we'll operate from a leased, fully fitted campus due to the timelines. We expect to begin with about 100 or so students and scale up year by year. Within two to three years, we'll assess the need for a permanent campus. We'll recruit faculty through a local entity, with some visiting from Scotland. However, most will be based in India and hired globally. Many will likely be Indian—after all, India already supplies talent to institutions worldwide. Quality is non-negotiable. All programs in India will go through the same rigorous approval and audit process as those in Aberdeen. Faculty will be vetted, and programs will be reviewed by academic oversight panels. The UGC also mandates parity, and we fully support that. Yes. We offer short-term academic exchanges. Students at the India campus will receive the same Aberdeen degree. Those who want the full Scottish experience are welcome to apply directly to our UK campus as international students. We're carefully studying the Indian market. This isn't about profit—it's about creating access. We plan to offer scholarships based on merit and financial need, just as we do in Aberdeen. Details are still being finalised. It's too early to say. Right now, we're focused on getting the Mumbai campus right. But we're excited about future possibilities. It's deeply personal. I was born in India and studied abroad. This feels like a homecoming. I'm proud to be part of this initiative. A few hundred postgraduates. We've had Indian students for decades, but numbers have grown significantly in the last five years. It will be equivalent and aligned. We may adapt certain elements to reflect local cultural or legal norms, but the quality and academic rigour will be the same. The Mumbai campus will be subject to the same academic scrutiny as Aberdeen. Research is integral. Undergraduate and postgraduate students will engage in dissertations. We'll build a research cohort over time, including PhD students. We're already in touch with India's National Research Foundation and are collaborating with Indian co-investigators on several grants. Our vision for students enrolled in the Branch campus is to offer an excellent education in Mumbai and a University of Aberdeen degree. We are exploring the option of short exchange visits to Scotland. Absolutely. Students who want that full cultural experience can apply to study at our UK campus. Students in India will receive the same degree—without needing to relocate. We're assessing affordability. All foreign universities are navigating this new Indian model. We're committed to keeping costs reasonable and offering scholarships to deserving students. This is not a revenue-maximising exercise. They'll be designed for the Indian context. We plan to reserve a portion of seats for scholarships, with selection based on merit or need. The details are still being worked out.

Trump mobile phone is here: Price, features, and everything you didn't ask for
Trump mobile phone is here: Price, features, and everything you didn't ask for

Time of India

time32 minutes ago

  • Time of India

Trump mobile phone is here: Price, features, and everything you didn't ask for

Memecoins are so passé; it's time for Trump mobile phones! In a move that has left tech enthusiasts and political pundits buzzing, Donald Trump Jr. and Eric Trump unveiled the Trump Mobile service. What's the occasion? Well, the Trump kids wanted to mark the 10th anniversary of Donald Trump's 2016 presidential campaign launch and do something special for their dad. Late Father's Day celebration much? Seems so! Late appreciation, new gimmick! Donald Trump Jr. and Eric Trump didn't just stop there. To make their dad proud and make America more tech-savvy, alongside the service – which is set to become available in September 2025 – the Trump kids introduced the T1 Phone—a gold-colored smartphone priced at $499, designed to cater to conservative consumers seeking a patriotic alternative in the tech market. What Is the T1 Phone? The T1 Phone is an Android-based device boasting a 6.8-inch AMOLED display, 256GB of storage, and a 50-megapixel camera. The device is marketed as being "Made in America," with the Trump Organization emphasizing domestic manufacturing and customer support. However, industry experts have expressed skepticism about these claims, citing the challenges of establishing the necessary infrastructure for smartphone production in the United States of America. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Blaydon-on-tyne: If You Were Born Between 1940-1975 You Could Be Eligible For This Life Cover Reassured Get Quote Undo How much does it cost? Priced at $499, the T1 Phone positions itself in the mid-range market segment. The accompanying mobile service plan, dubbed "The 47 Plan," offers unlimited talk, text, and data within the US, along with benefits such as 5G access, roadside assistance, and telehealth services. The plan is priced at $47.45 per month, which is seemingly a (not so) clever nod to Trump's status as both the 45th and 47th president of the United States. Made in America, really? While the Trump Organization promotes the T1 Phone as being "Made in America," the feasibility of entirely domestic production remains uncertain. Critical smartphone components like processors, displays, and camera sensors are typically sourced globally, and final assembly traditionally occurs in Asia. No wonder the claim of a fully US-made device is met with skepticism by industry analysts! The obvious meme factor The T1 Phone's gold-colored design and the "Made in America" branding are clearly aimed at appealing to patriotic consumers. However, the device's actual specifications and features place it in direct competition with established mid-range smartphones from companies like Samsung and OnePlus. The question remains: does the gold finish and political branding justify the price tag, or is it a golden gilded gimmick? Only time will tell! Trump's Meme Coin Gala a FLOP? Guests Reveal Bad Food, No Booze & Chaos | WATCH

India pharma market grows 6.9 pc in May, chronic therapies lead
India pharma market grows 6.9 pc in May, chronic therapies lead

Hans India

time32 minutes ago

  • Hans India

India pharma market grows 6.9 pc in May, chronic therapies lead

New Delhi: The India pharma market (IPM) grew 6.9 per cent (on-year) in May, driven by strong outperformance in cardiac, respiratory, and anti-diabetes therapies, a report showed on Tuesday. In May, Indian companies grew 6.6 per cent, while MNCs grew 8.4 per cent YoY. Acute therapy growth stood at 5 per cent in May, the second consecutive month of muted YoY growth, according to the report by Motilal Oswal Financial Services Ltd. For the 12 months ending in May, IPM growth was led by price/new launches/volume growth of 4.2 per cent/2.3 per cent/1.1 per cent YoY. As of May, the Indian pharma companies held a majority share of 83 per cent in IPM, with the remaining held by multi-national pharma companies (MNCs). In May, among the top 20 pharma companies, JB Chem (up 11.6 per cent YoY), Glenmark (up 11.8 per cent YoY), and Ajanta (up 10.6 per cent YoY) recorded higher growth rates vs IPM. Ajanta outperformed IPM, led by strong double-digit growth across key therapies like Anti Diabetic/Ophthal. JB Chemicals outperformed IPM, led by a strong show in Cardiac/Ophthal/Anti Parasitic. On a MAT basis, the industry reported 7.6 per cent YoY growth. Chronic therapies witnessed 10 per cent YoY growth, while acute therapies displayed 5 per cent YoY growth in May, said the report. Meanwhile, India's pharmaceutical industry, which has emerged as the largest supplier of affordable generic medicines, is poised to grow at 7.8 per cent year-on-year in April 2025 driven by strong demand and new products, according to experts at India Ratings. The country's pharma sector is now ranked 3rd in volume and 14th in value globally and contributes as much as 20 per cent of the world's supply of medicines. The turnover of the Indian pharma industry touched Rs 4,17,345 crore in 2023-24 growing steadily at over 10 per cent annually for the past five years.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store